2019 International Congress » Non-Motor Symptoms

Date: Wednesday, September 25, 2019

Time: 1:15pm-2:45pm

Location: Agora 3 West, Level 3

Meeting: 2019 International Congress

1:15pm-2:45pm: (Not) sleeping with the enemy: Cognitive correlates of nocturnal sleep disturbances in Parkinson’s disease

S. Castillo-Torres, C. Cerda-Contreras, D. Roque-Martínez, D. Díaz-Pérez, X. Ortiz-Jiménez, B. Chávez-Luévanos, I. Estrada-Bellmann (Monterrey, Mexico)

1:15pm-2:45pm: A Comparative Study of Measured and Predicted Metrics of Respiratory Function in People with Parkinson’s Disease (PD)

L. Mcmahon, O. Lennon, C. Blake, D. Mcgrath (Dublin, Ireland)

1:15pm-2:45pm: A Dual-Center Study of Pain and Other Non-motor Symptoms in Parkinson disease

P. Ghosh, P. Imbriani, N. Caputi, L. Covington, A. Sparks, T. Schirinzi, Y. Salnikova, S. Natoli, A. Pisani (Washington Dc, DC, USA)

1:15pm-2:45pm: A new screening tool to detect psychoaffective states in patients with Parkinson´s disease

C. Schedlich-Teufer, M. Sommerauer, S. Jost, S. Schnitzler, H. Dafsari, E. Kalbe, J. Kessler, M. Barbe (Cologne, Germany)

1:15pm-2:45pm: A Prospective Study of the Effects of Deep Brain Stimulation on Constipation and Olfaction in Parkinson Disease

S. Kola, A. Bharucha, D. Prichard, K. Feuerhak, A. Hassan (Rochester, MN, USA)

1:15pm-2:45pm: A Study of Social Cognition in Parkinson’s Disease

S. Meenakshisundaram, LN. Ranganathan (Chennai, India)

1:15pm-2:45pm: Actigraphically Characterized Infradian Rest-Activity Rhythms in Parkinson’s Disease

C. Brooks, R. Koehler, MK. Erb, F. Mortazavi, J. Bhangu, K. Thomas (Boston, MA, USA)

1:15pm-2:45pm: Adrenergic Receptor Modulation of Non-Motor Symptoms in Parkinson’s Disease

M. Rangwala, E. Hogg, E. Tan, H. Lu, A. Garland Becerra, M. Tagliati (Los Angeles, CA, USA)

1:15pm-2:45pm: Alterations of Blood Pressure Circadian Rhythm in Alpha-Synucleinopathies

A. Romagnolo, F. Vallelonga, A. Merola, C. Di Stefano, G. Sobrero, V. Milazzo, M. Zibetti, CA. Artusi, M. Fabbri, MG. Rizzone, S. Maule, L. Lopiano (Turin, Italy)

1:15pm-2:45pm: Anxiety and dopaminergic stimulation in patients with Parkinson´s disease.

A. Camacho Nieto, AR. Franco Salinas, L. Ruiz-Escribano Menchen, MJ. Gallardo Alcañiz, JP. Cabello Rosa, J. Vaamonde Gamo (Ciudad Real, Spain)

1:15pm-2:45pm: Apathy and cognitive profile in Parkinson´s disease: A cross-sectional study in Cali-Colombia

B. Muñoz, J. Valderrama, L. Botero, J. Orozco (Cali, Colombia)

1:15pm-2:45pm: Applicability of questionnaires and study of the prevalence of REM Sleep Behavior Disorder (RBD) in Parkinson’s disease

M. Cordellini, A. Machado, C. Costa (Curitiba, Brazil)

1:15pm-2:45pm: Association between alteration in social cognition and impulse control disorder in Parkinson’s disease

L. Zuazua-Vidal, M. Rodríguez-Violante, R. Solís-Vivanco, A. Pérez-González, A. Alcocer-Salas, A. Cervantes-Arriaga (Mexico City, Mexico)

1:15pm-2:45pm: Association of alexithymia and Parkinson’s Disease (PD) in Mexican population

L. Zuazua, M. Rodriguez, A. Cervantes, A. Balderas, R. Cruz, A. Alcocer, A. Perez, O. Esquivel, L. Navarro (Mexico City, Mexico)

1:15pm-2:45pm: Auditory processing in young patients of Essential Tremor

P. Shetty, Y. Belur, R. Yadav, P. Yuvaraj, A. Rajasekaran, N. Shivashankar, S. Hegde, P. Pal (Bangalore, Karnataka, India)

1:15pm-2:45pm: Autonomic dysfunction in early Parkinson’s disease: a prospective study

I. Stankovic, I. Petrovic, T. Pekmezovic, V. Markovic, T. Stojkovic, N. Dragasevic Miskovic, M. Svetel, V. Kostic (Belgrade, Serbia)

1:15pm-2:45pm: Beneficial effect of 36-month bilateral subthalamic stimulation on quality of sleep compared to standard-of-care medication in Parkinson’s disease

H. Dafsari, S. Jost, A. Sauerbier, V. Visser-Vandewalle, K. Ashkan, M. Silverdale, J. Evans, P. Löhrer, A. Rizos, JN. Petry-Schmelzer, G. Fink, M. Barbe, A. Antonini, P. Martinez-Martin, K. Ray-Chaudhuri, L. Timmermann (Cologne, Germany)

1:15pm-2:45pm: Bladder Training for Urinary Tract Symptoms in PD – A Randomised Controlled Trial

C. Mcdonald, J. Rees, K. Winge, J. Newton, D. Burn (Gateshead, United Kingdom)

1:15pm-2:45pm: Characteristics of lower gastrointestinal tract dysfunction in patients with Parkinson disease

T. Uchiyama, T. Yamamoto, K. Suzuki, T. Kadowaki, H. Nakajima, R. Sakakibara, S. Kuwabara, K. Hirata, M. Murai (Chiba, Japan)

1:15pm-2:45pm: Characteristics of the clinical and cerebral metabolism in Parkinson’s disease with atrophy in nucleus basalis of Meynert

MY. Gang, T. Baba, Y. Hosokai, Y. Nishio, A. Kikuchi, K. Hirayama, T. Hasegawa, M. Aoki, A. Takeda, E. Mori, K. Suzuki (Sendai, Japan)

1:15pm-2:45pm: Characterization of the gastrointestinal dysfunction in the 6-hydroxydopamine rat model of Parkinson’s disease

X. Chai, S. Diwakarla, R. Pustovit, R. Mcquade, M. Di Natale, C. Ermine, C. Parish, D. Finkelstein, J. Furness (Melbourne, Australia)

1:15pm-2:45pm: Characterizing olfactory impairment in patients with Parkinson’s disease and related disorders

Y. Watanabe, K. Suzuki (Mibu, Shimotsuga, Tochigi, Japan)

1:15pm-2:45pm: Circadian and Homeostatic Modulation of Multi-unit Activity in Dopaminergic and Striatal Structures

K. Fifel, T. Deboer (Leiden, Netherlands)

1:15pm-2:45pm: Clinical-instrumental algorithm for assessment visuospatial dysfunction in patients with Parkinson’s disease

K. Stepanchenko (Kharkiv, Ukraine)

1:15pm-2:45pm: Cognitive and psychiatric course in the initial lustrum of Parkinson disease: the glass is half full

D. Weintraub, C. Caspell-Garcia, H. Cho, T. Simuni, A. Siderowf, C. Coffey, D. Aarsland, R. Alcalay, L. Chahine, J. Eberling, A. Espay, J. Hamilton, J. Leverenz, I. Litvan, I. Richard, L. Rosenthal, M. York (Philadelphia, PA, USA)

1:15pm-2:45pm: Cognitive changes after deep brain stimulation of the subthalamic nucleus in Parkinson’s disease: A longitudinal study.

J. Mana, F. Růžička, A. Fečíková, E. Růžička, D. Urgošík, R. Jech, O. Bezdicek (Prague, Czech Republic)

1:15pm-2:45pm: Cognitive impairment in patients with Parkinson’s Disease

E. Kolupaeva, I. Zhukova, N. Zhukova, M. Nikitina, O. Izhboldina, I. Mironova, Z. Kislukhina (Tomsk, Russian Federation)

1:15pm-2:45pm: Cognitive Inhibitory Control and Response to Dopaminergic Medication in Parkinson’s Disease

M. El Haddouchi, A. Handberg, K. Svaerke, A. Loekkegaard (Copenhagen, Denmark)

1:15pm-2:45pm: Cognitive Processes That Indirectly Effect Olfactory Dysfunction in Parkinson’s Disease

B. Chase, A. Mertens, J. Santo, K. Markopoulou (Omaha, NE, USA)

1:15pm-2:45pm: Comparison between the Movement Disorders Society – Non-Motor Rating Scale (MDS-NMS) and the Non-Motor Symptoms Scale (NMSS)

A. Schrag, A. Rizos, C. Rodriguez-Blazquez, D. Weintraub, KR. Chaudhuri, P. Martinez-Martin (Madrid, Spain)

1:15pm-2:45pm: Comparison of autonomic symptoms on Parkinson’s disease and essential tremor with SCOPA-AUT

J. Gonzalez (Lima, Peru)

1:15pm-2:45pm: Comparison of Zonisamide with Non-Levodopa, Anti-Parkinson’s disease Drugs in the Incidence of Parkinson’s Disease-Relevant Symptoms

H. Iwaki, M. Tagawa, K. Iwasaki, K. Kawakami, M. Nomoto (Toon, Japan)

1:15pm-2:45pm: Construct validity of the Movement Disorders Society – Non Motor Rating Scale (MDS-NMS)

KR. Chaudhuri, A. Rizos, C. Rodriguez-Blazquez, D. Weintraub, A. Schrag, P. Martinez-Martin (London, United Kingdom)

1:15pm-2:45pm: Daily variability of non-motor symptoms as a reflection of circadian dysregulation in Parkinson’s disease

O. Alenikova, S. Likhchev, A. Buniak, M. Liashkovich (Minsk, Belarus)

1:15pm-2:45pm: Data quality, acceptability and reliability of the Movement Disorders Society – Non Motor Rating Scale (MDS-NMS)

C. Rodriguez-Blazquez, A. Schrag, D. Weintraub, A. Rizos, KR. Chaudhuri, P. Martinez-Martin (Madrid, Spain)

1:15pm-2:45pm: Deceleration capacity of heart rate: is cardiac vagal modulation impaired in idiopathic Parkinson’s disease?

C. Carricarte Naranjo, C. Marras, N. Visanji, D. Cornforth, L. Sanchez-Rodriguez, B. Schüle, S. Goldman, M. Estevez, P. Stein, A. Lang, H. Jelinek, A. Machado (La Habana, Cuba)

1:15pm-2:45pm: Decreased baroreflex sensitivity in Parkinson’s disease is associated with orthostatic hypotension

P. Turcani, P. Valkovic, P. Siarnik, S. Sutovsky (Bratislava, Slovakia)

1:15pm-2:45pm: Deep Brain Stimulation of Subthalamic Nucleus (DBS-STN) in Parkinson Disease (PD): Acute Clinical Effects in Hypothalamic control

D. Dos Santos, E. Barbosa, R. Cury (São Paulo, Brazil)

1:15pm-2:45pm: Deep Brain Stimulation of the Subthalamic Nucleus and Globus Pallidus for apathy in PD patients

X. Zhang, A. Xie (Qingdao, China)

1:15pm-2:45pm: Depression as a risk factor for impulse compulsive disorders in Parkinson’s disease: a prospective survival study

J. Marín-Lahoz, F. Sampedro, S. Martinez-Horta, J. Pagonabarraga, J. Kulisevsky (Barcelona, Spain)

1:15pm-2:45pm: Effect of Deep brain stimulation and Continuous infusion of levodopa-carbidopa intestinal therapy on non-motor symptoms in patients with advance Parkinson’s disease

V. Vuletic (Rijeka, Croatia)

1:15pm-2:45pm: Effect of non-contact boxing on non-motor symptoms in Parkinson’s disease

A. Ghaffar, R. Gallagher, L. Rubin, S. Dharia, L. Ketigian, J. Whalen, Z. Scheid, K. Patel, J. Zhu, C. Michaelides, A. Leder (Old Westbury, NY, USA)

1:15pm-2:45pm: Evaluation of gut microbiota in patients with Parkinson’s disease using a gas chromatography–mass spectrometry in Russia

I. Krasakov, I. Litvinenko (Saint-Petersburg, Russian Federation)

1:15pm-2:45pm: Evaluation of the Zeez Sleep Pebble for Sleep Disturbance in Parkinson’s Disease

S. Milne, S. Cummins, C. Carroll (Plymouth, United Kingdom)

1:15pm-2:45pm: Exploratory analysis of the relationship between pain and mood disturbances in Parkinson’s disease

C. Vila, A. Sparks, P. Imbriani, N. Caputi, L. Covington, T. Schirinzi, S. Natoli, A. Pisani, P. Ghosh (Washington, DC, USA)

1:15pm-2:45pm: Exploring the Lexicon of Fatigue in Parkinson Disease: A Qualitative Approach

S. Mantri, S. Albert, S. Kahl, M. Daeschler, E. Mamikonyan, C. Kopil, C. Marras, L. Chahine (Durham, NC, USA)

1:15pm-2:45pm: Exploring the relationship between motor and non-motor fluctuations in Parkinson’s disease: patient’s perspective, clinician’ s assessment and objective measures from a wearable device

A. Leake, A. de Angelis, M. Horne, D. Paviour, J. Coebergh, M. Edwards, F. Morgante, L. Ricciardi (London, United Kingdom)

1:15pm-2:45pm: Fatigue in Parkinson’s Disease

D. Silva, TR. Alcântara-Silva, AL. Alcântara-Silva, S. Suzuki-Godoy (Goiânia, Brazil)

1:15pm-2:45pm: Fatigue in Parkinson’s disease and its relation with disease duration and treatment

D. Nassif, J. Pereira (Rio de Janeiro, Brazil)

1:15pm-2:45pm: Frailty status predicts falls in early Parkinson’s disease

S. Holland, R. Morris, B. Galna, L. Rochester, A. Yarnall (Newcastle Upon Tyne, United Kingdom)

1:15pm-2:45pm: Frequency, course and predictors of fatigue in Parkinson’s disease patients and population-based controls

E. Warrlich, EJ. Vollstedt, R. Modreanu, B. Hauptmann, V. Tadic, S. Tunc, C. Kritzinger, J. Prasuhn, A. Balck, M. Borsche, H. Hanssen, N. Brüggemann, C. Klein, M. Kasten (Luebeck, Germany)

1:15pm-2:45pm: Functional Bowel Symptoms in Parkinson´s Disease

K. Murtomäki, T. Mertsalmi, E. Jaakkola, E. Mäkinen, J. Joutsa, R. Levo, E. Pekkonen, V. Kaasinen, F. Scheperjans (Hus, Finland)

1:15pm-2:45pm: Gastrointestinal disorders in various forms of parkinsonism

R. Matmurodov, KH. Khalimova, EL. Abduqodirov (Tashkent, Uzbekistan)

1:15pm-2:45pm: Gastrointestinal microbiome in Parkinson’s disease in a Bavarian cohort

F. Marxreiter, A. Cosma-Grigorov, H. Gassner, H. Meixner, Z. Kohl, M. Neurath, S. Wirtz, J. Winkler (Erlangen, Germany)

1:15pm-2:45pm: Gastrointestinal symptoms predict cognitive decline in Parkinson’s Disease

A. Gonçalves, A. Mendes, N. Vila-Chã, I. Moreira, S. Cavaco (Porto, Portugal)

1:15pm-2:45pm: Glycopyrrolate as inhalation for treating sialorrhea in Parkinson’s Disease

L. Velzen, J. Masselink, L. Dorresteijn, K. Movig (Enschede, Netherlands)

1:15pm-2:45pm: Gustatory Connectivity in Parkinson’s Disease Progression

H. Chatterjee, G. Elumalai, N. Sewram, N. Osakwe (Georgetown, Guyana)

1:15pm-2:45pm: Health associated quality of life (HAQL) and humor/cognitive complaints predict mortality in Parkinson’s disease (PD)

P. Bugalho, R. Barbosa, F. Ladeira, J. Marto, C. Borbinha, L. Conceição, M. Saraiva, M. Salavisa, B. Meira, M. Fernandes (Lisbon, Portugal)

1:15pm-2:45pm: Higher levels of physical activity is associated with fewer non-motor symptoms in early Parkinson’s disease: a 1-year follow-up study

S. Ng, N. Chia, M. Abbas, KY. Tay, WL. Au, EK. Tan, L. Tan (Singapore, Singapore)

1:15pm-2:45pm: How Parkinson’s Disease Affects Value-Based Decisions

L. Montaser-Kouhsari, R. Gerraty, A. Bakkour, D. Shohamy (New York, NY, USA)

1:15pm-2:45pm: Hyposmia as a marker of (non-)motor disease progression in Parkinson’s disease

D. Roos, J. Twisk, P. Raijmakers, R. Doty, H. Berendse (Amsterdam, Netherlands)

1:15pm-2:45pm: IMPACT OF PAIN ON STROKE AND HYPERTENSION AS COMORBIDITIES IN PARKINSON’S DISEASE

V. Wijaya, R. Pinzon, A. Al Jody (Yogyakarta, Indonesia)

1:15pm-2:45pm: Impulse control and pain : a link in Parkinson’s disease.

G. Albani, L. Pradotto, G. Veneziano, P. Cipresso, E. Pedroli, F. Scarpina, A. Mauro, M. Semonella, A. Cistaro (Piancavallo-Verbania, Italy)

1:15pm-2:45pm: Impulse Control Disorders in a Brazilian population with Parkinson´s disease -an observational study

B. Veiga, V. Borges, H. Ferraz, C. Aquino, C. Giacominelli, SM. Silva, S. Lestingi (São Paulo, Brazil)

1:15pm-2:45pm: Influence of cognitive abilities on prominence production in mild dysarthric patients with Parkinson’s disease

T. Thies, D. Mücke, A. Lowit, J. Steffen, E. Kalbe, M. Barbe (Cologne, Germany)

1:15pm-2:45pm: Influence of Cognitive Deficits and Tremor Severity of the Development of Depression in Nondemented Patients with Essential Tremor

M. Petrova, O. Grigorova, M. Raycheva, L. Traykov (Sofia, Bulgaria)

1:15pm-2:45pm: Influence of controlled-release levodopa on quality of sleep and nocturnal movements

E. Schaeffer, L. Zaunbrecher, I. Liepelt-Scarfone, C. Hansen, W. Maetzler, S. Nussbaum, B. Roeben, M. Elshehabi, P. Saraykin, S. Otterbein, J. Busch, D. Berg (Kiel, Germany)

1:15pm-2:45pm: Instrumental evaluation of sleep disturbance and autonomic nervous system dysfunction in idiopathic Parkinson’s disease

MD. Doręgowska, MT. Toś, JM. Malkiewicz, JS. Siuda, MR. Rudzińska-Bar (Katowice, Poland)

1:15pm-2:45pm: Intestinal nerve damage and gut dysfunction in mouse models of Parkinson’s Disease

R. Mcquade, R. Constable, E. Lei, M. Di Natale, J. Berger, J. Kauhausen, C. Parish, D. Finkelstein, J. Furness, S. Diwakarla (Melbourne, Australia)

1:15pm-2:45pm: Investigation of back pain in patients with Parkinson’s Disease

O. Yaremchuk, I. Yaremchuk (Chernivtsi, Ukraine)

1:15pm-2:45pm: Levocarb-induced diplopia in idiopathic Parkinson’s disease: a case report

S. Joza, F. Ba (Edmonton, AB, Canada)

1:15pm-2:45pm: Levodopa/carbidopa Intestinal Gel in Treatment of Non-Motor Symptoms in Advanced Parkinson’s Disease

W. Kamel, J. Al Hashel (Beni Suef, Egypt)

1:15pm-2:45pm: Long term evolution of ventilatory function in Parkinson’s disease

G. Baille, C. Chenivesse, T. Perez, D. Devos, L. Defebvre, C. Moreau (Lille, France)

1:15pm-2:45pm: Longitudinal Cortical Changes Associated with Apathy in Parkinson’s Disease

E. Canu, F. Agosta, F. Imperiale, T. Stojković, I. Stankovic, S. Basaia, A. Fontana, V. Markovic, I. Petrović, E. Stefanova, V. Kostic, M. Filippi (Milan, Italy)

1:15pm-2:45pm: Mandibular Advancement Device in Parkinson’s disease: an efficacious and usable device in a disabling disease

V. Cochen Decock, M. Castel, I. Bonafé (Montpellier, France)

1:15pm-2:45pm: Measurement properties of the MDS-NMS Non-motor Fluctuations Subscale

MJ. Forjaz, A. Ayala, C. Rodriguez-Blazquez, A. Schrag, D. Weintraub, A. Rizos, KR. Chaudhuri, P. Martinez-Martin (Philadelphia, PA, USA)

1:15pm-2:45pm: MIBG myocardial scintigraphy identifies premotor PD/DLB during a negative DAT scan period

R. Sakakibara, F. Tateno, Y. Aiba (Sakura, Japan)

1:15pm-2:45pm: Mindfulness Training to Reduce Anxiety in Parkinson’s Disease: A Cautionary Tale about Wearable Technology

D. Mohanty, A. Lingaiah, J. Doak, A. Jacob, R. Castellanos, V. Holiday, A. Espay, K. Lafaver (Louisville, KY, USA)

1:15pm-2:45pm: Motor and non-motor symptoms differences between Vascular Parkinsonism (VP) and Parkinson’s Disease (PD) patients in early stages

R. Raimundo, M. Mendes, R. Jesus, C. Azoia, A. Almeida, AG. Velon (Vila Real, Portugal)

1:15pm-2:45pm: Motor and non-motor symptoms related to sleep disturbances in Parkinson’s disease

D. van Wamelen, V. Leta, A. Podlewska, Y. Wan, A. Sauerbier, A. Rizos, P. Martinez-Martin, K. Chaudhuri (Madrid, Spain)

1:15pm-2:45pm: Non motor fluctuations in Parkinson’s disease: Findings from a Tunisian cohort

M. Ben Djebara, K. Laabidi, A. Nasri, A. Rekik, S. Mrabet, A. Gargouri, I. Kacem, R. Gouider (Tunis, Tunisia)

1:15pm-2:45pm: Non motor symptoms Parkinson’s disease

N. Bagdanova, Z. Zuleiha (Kazan, Russian Federation)

1:15pm-2:45pm: Non-motor symptoms burden grading in Parkinson disease with the Movement Disorders Society – Non-Motor Rating Scale (MDS-NMS)

D. Weintraub, C. Rodriguez-Blazquez, A. Schrag, A. Rizos, KR. Chaudhuri, P. Martinez-Martin (Madrid, Spain)

1:15pm-2:45pm: Non-motor symptoms burden is greater in early Parkinson’s disease patients with motor complications

D. Santos, T. de Deus, E. Suárez Castro, A. Aneiros, S. Jesús, M. Aguilar, LL. Planellas, J. García Caldentey, N. Caballol, B. Vives, J. Hernández Vara, I. Cabo, L. López Manzanares, I. González Aramburu, MA. Avila, MJ. Catalán, L. López Díaz, JM. García Moreno, B. Solano, M. álvarez Sauco, L. Vela, S. Escalante, E. Cubo, F. Carrillo, JC. Martínez Castrillo, P. Sánchez Alonso, MG. Alonso Losada, N. López Ariztegui, P. Martínez Martín, SG. Coppadis (A Coruña, Spain)

1:15pm-2:45pm: Non-motor Symptoms in Hyperkinetic Movement Disorders

H. Egit, M. Balal, M. Demirkiran (Adana, Turkey)

1:15pm-2:45pm: Non-motor symptoms in Parkinson disease motor subtypes: a study using the new MDS-NMS

P. Martinez-Martin, C. Rodriguez-Blazquez, A. Schrag, D. Weintraub, A. Rizos, KR. Chaudhuri (Madrid, Spain)

1:15pm-2:45pm: Non-Motor Symptoms in Patients with Parkinson’s Disease: Effect of Gender, Disease Severity, and Disease Phenotype

V. Holla, A. Lenka, S. Chaithra, A. Stezin, S. Prasad, N. Kamble, R. Yadav, P. Pal (Bengaluru, India)

1:15pm-2:45pm: Nonmotor Symptoms in Parkinson’s Disease: 36-month Follow-up Study Comparing Bilateral Subthalamic Stimulation and Standard-of-care Medication

S. Jost, A. Sauerbier, K. Ray-Chaudhuri, V. Visser-Vandewalle, K. Ashkan, M. Silverdale, J. Evans, A. Rizos, A. Schnitzler, P. Löhrer, JN. Petry-Schmelzer, M. Barbe, A. Antonini, P. Martinez-Martin, G. Fink, L. Timmermann, H. Dafsari (Cologne, Germany)

1:15pm-2:45pm: Olfactory dysfunction in Parkinson’s disease

N. Jalami, H. Bentahar, M. Chraa, N. Kissani (Marrakech, Morocco)

1:15pm-2:45pm: Olfactory Hallucinations as a Non-motor sign of Parkinson’s disease- a cross sectional study

S. Chandra, M. Schiess, R. Mehanna (Houston, TX, USA)

1:15pm-2:45pm: Parkinson’s Panorama: Epidemiology and Non-motor Symptoms, Revisiting Taboo Topic of Sexual Dysfunction in a Malaysian Parkinson’s Population

Y Y. Tan, K. Tan (Georgetown, Malaysia)

1:15pm-2:45pm: Predictors of Orthostatic Hypotension in Patients with Parkinson’s Disease

C-C. Lin, J. Heisler, H. Patel, W. Ondo (Houston, TX, USA)

1:15pm-2:45pm: Predictors of refractory impulse control disorder to dopamine agonists substitution therapy in Parkinson’s disease patients

JY. Lee, J-H. Choi, B. Jeon, J. Cho (Seoul, Republic of Korea)

1:15pm-2:45pm: Prevalence and factors related to orthostatic hypotension and orthostatic intolerance in recently-diagnosed, drug-naïve Parkinson’s disease patients

S. Perez-Lloret, C. Quarracino, F. Capani, M. Otero-Losada (Buenos Aires, Argentina)

1:15pm-2:45pm: Prevalence of orthostatic hypotension and postprandial hypotension in neurodegenerative diseases with synucleinopathy: a systematic review and meta-analysis

CS. Chuang, SL. Wu (Changhua, Taiwan)

1:15pm-2:45pm: Professional characteristics of people with or without impulse control disorders in Parkinson’s disease from a single centre cohort study, Moscow, Russia

N. Titova, N. Shipilova, E. Katunina (Moscow, Russian Federation)

1:15pm-2:45pm: Prospective Memory in Parkinson’s Disease: the role of the motor subtypes

A. D'Iorio, G. Maggi, C. Vitale, D. Di Meglio, L. Trojano, G. Santangelo (Caserta, Italy)

1:15pm-2:45pm: Pursuit of Psychosocial Intervention for Depression and Anxiety in Japanese Parkinson’s Disease patients: Two Studies of Cognitive Behavioral Therapy

I. Shinmei, N. Nishikawa (Tokyo, Japan)

1:15pm-2:45pm: Relationship between non-motor symptoms, medications and sleep interruptions in patients with Parkinson’s disease

S. Anis, A. Thaler, M. Kestenbaum, A. Orr-Urtreger, M. Gana-Weisz, O. Goldstein, R. Hen Simon, J. Cederbaum, J. Hausdorff, N. Giladi, A. Mirelman (Tel Aviv, Israel)

1:15pm-2:45pm: Relationship between pain and autonomic symptoms in Parkinson’s Disease: a double-center, cross-sectional, observational study.

P. Imbriani, P. Ghosh, T. Schirinzi, N. Caputi, L. Covington, A. Sparks, Y. Salnikova, S. Natoli, A. Pisani (Rome, Italy)

1:15pm-2:45pm: Relationship between RBD and olfactory disorder, clinical symptoms in Parkinson’s disease

M. Iijima, F. Yoshi, K. Suzuki, S. Nogawa, T. Osada, H. Hirata, K. Kitagawa, N. Hattori, Y. Okuma (Tokyo, Japan)

1:15pm-2:45pm: Relationships of gender, care models, and neuropsychiatric symptoms in Parkinson’s disease

J. Goldman, S. Wu, C. Martinez-Rubio, V. Todaro (New York, NY, USA)

1:15pm-2:45pm: Repetitive transcranial magnetic stimulation (rTMS) for the treatment of pain in Parkinson’s Disease – an open-label study

M. Bonello, T. Nurmikko, A. Mavrianou, M. Steiger (Liverpool, United Kingdom)

1:15pm-2:45pm: Retronasal olfactory function in Parkinson’s disease

E. Aubry-Lafontaine, C. Tremblay, P. Durand-Martel, N. Dupré, J. Frasnelli (Trois-Rivières, QC, Canada)

1:15pm-2:45pm: Specific chemosensory pattern in Parkinson’s disease

C. Tremblay, R. Emrich, A. Cavazzana, L. Klingelhoefer, M. Brandt, T. Hummel, A. Haehner, J. Frasnelli (Trois-Rivières, QC, Canada)

1:15pm-2:45pm: Speech and swallowing disorders in Parkinson’s disease – is there a link?

N. Madetko, S. Budrewicz (Wrocław, Poland)

1:15pm-2:45pm: Structural connectome of brainstem nuclei in REM sleep behavior disorder, a model of premanifest synucleinopathy

MG. García-Gomar, LD. Lewis, L. Wald, B. Rosen, A. Videnovic, M. Bianciardi (Boston, MA, USA)

1:15pm-2:45pm: Subacute Encephalopathy with Pimavanserin Treatment in Parkinson Disease

J. King, G. Volkell, J. Wyant, E. Molho (Albany, NY, USA)

1:15pm-2:45pm: Systematic Review of Non-pharmacological Interventions for Respiratory Health in Parkinson’s Disease (PD)

L. Mcmahon, O. Lennon, C. Blake (Dublin, Ireland)

1:15pm-2:45pm: The effect of dopaminergic therapy on functional connectivity in patients with Parkinson’s disease and visual hallucinations

A. Powell, J. Shine, S. Lewis (Sydney, Australia)

1:15pm-2:45pm: The effect of istradefylline on mood disorders in Parkinson’s disease

H. Nagayama, O. Kano, H. Murakami, M. Hamada, R. Sengoku, Y. Shim, T. Toda (Tokyo, Japan)

1:15pm-2:45pm: The effect of Levodopa-Carbidopa Intestinal Gel on Non-Motor Symptoms, Specificly Autonomic Dysfunctions

H. Ekmekci, M. Gültekin (Ankara, Turkey)

1:15pm-2:45pm: The frequency of lower urinary tract symptoms in patients with Parkinson’s disease and Clinical efficacy of istradefylline

Y. Higashi, M. Tabata, T. Tabuchi (Himeji, Japan)

1:15pm-2:45pm: The impact of non-motor symptoms on the quality of life of patients with Parkinson’s disease depending on its stages

K. Abdurakhmonova, G. Rakhimbaeva (Tashkent, Uzbekistan)

1:15pm-2:45pm: The influence of baseline body mass index on cognitive decline in Parkinson’s disease

SY. Kang, HS. Yoo, SJ. Chung, YH. Sohn, PH. Lee (Seoul, Republic of Korea)

1:15pm-2:45pm: The influence of physical activities on cognition in small group of Parkinson’s Disease patients

J. Silva, M. Pereira, L. Piovesara, P. Azevedo, F. Cendes, A. D'Abreu, R. Guimarães (Campinas, Brazil)

1:15pm-2:45pm: The Influence of Sociodemographic Factors on Post-DBS Impulse Control Symptom Severity in Parkinson’s Disease

H. Combs, A. Strutt, J. Jimenez-Shahed, N. Niemann, A. Viswanathan, M. York (Houston, TX, USA)

1:15pm-2:45pm: The prevalence and features of REM sleep behaviour disorder in Essential Tremor: a polysomnography study

P. Bugalho, M. Salavisa, C. Borbinha, M. Fernandes, B. Meira, R. Barbosa, M. Mendonça (Lisboa, Portugal)

1:15pm-2:45pm: The prevalence of supine hypertension and nocturnal hypertension and the difference of blood pressure in each sleep position in Parkinson’s disease

J. Sringean, R. Hamindra, R. Bhidayasiri (Bangkok, Thailand)

1:15pm-2:45pm: The Relationship of Neuropsychiatric Symptoms and Cognitive Impairment in Parkinson’s Disease

B. Bernard, G. Stebbins, A. Negron, D. Merkitch, J. Goldman (Chicago, IL, USA)

1:15pm-2:45pm: The relationship of non-motor symptoms with the dominant symptom and the stage of patients with Parkinson’s disease

E. Tur, M. Demir, G. Kenangil (Istanbul, Turkey)

1:15pm-2:45pm: The social interaction in patients with Parkinson’s disease from the points of activities of daily living and motor function

A. Kumon, M. Sagawa, M. Saruwatari, N. Kawashima, K. Hasegawa (Fujisawa, Japan)

1:15pm-2:45pm: The Urge to Move in Restless Legs Syndrome Associated with Parkinson’s Disease: A Motor Impulse Control Disorder?

A. Marques, C. Lambert, T. Vidal, F. Durif, M. Fantini (Clermont-Ferrand, France)

1:15pm-2:45pm: Transient orthostatic blood pressure changes in Parkinson’s Disease: impact on falls, syncope and orthostatic intolerance

A. Fanciulli, N. Campese, G. Goebel, J. Ndayisaba, S. Eschlboeck, C. Kaindlstorfer, C. Raccagni, R. Granata, U. Bonuccelli, R. Ceravolo, W. Poewe, G. Wenning (Innsbruck, Austria)

1:15pm-2:45pm: Urodynamic study to distinguish multiple system atrophy from Parkinson’s disease

KW. Park, JH. Shin, NR. Choi, SY. Jo, MS. Choo, SJ. Chung (Seoul, Republic of Korea)

« View all sessions from the 2019 International Congress.